BG103861A - 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds - Google Patents

6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Info

Publication number
BG103861A
BG103861A BG103861A BG10386199A BG103861A BG 103861 A BG103861 A BG 103861A BG 103861 A BG103861 A BG 103861A BG 10386199 A BG10386199 A BG 10386199A BG 103861 A BG103861 A BG 103861A
Authority
BG
Bulgaria
Prior art keywords
aminopyrido
disubstituted
compounds
pyrimidine compounds
therapeutically effective
Prior art date
Application number
BG103861A
Other languages
Bulgarian (bg)
Inventor
Shripad Bhagwat
Chih-Hung Lee
Richard Perner
Ya-Gui Gu
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG103861A publication Critical patent/BG103861A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The compounds have the formula where R1, R2, R3 & R4 are variants and are selected from the groups including alkyl, aryl, heteoraryl and heterocycle and their substituted variants. The invention also relates to a method for the adenosinekinase inhibition by the applications including a therapeutically effective quantity of them in combination with a pharmaceutically acceptable carrier. The invention also relates to a method for the treatment of cerebral ischaemia, epilepsy, pain, inflammation and sepsis in mammals where therapeutically effective quantity of the compounds is applied, and to methods for their preparation. 18 claims
BG103861A 1997-04-16 1999-11-05 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds BG103861A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83439397A 1997-04-16 1997-04-16
PCT/US1998/004127 WO1998046603A1 (en) 1997-04-16 1998-04-16 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
BG103861A true BG103861A (en) 2000-06-30

Family

ID=25266829

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103861A BG103861A (en) 1997-04-16 1999-11-05 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Country Status (20)

Country Link
EP (1) EP0979230A1 (en)
JP (1) JP2001520649A (en)
KR (1) KR20010006453A (en)
CN (1) CN1259948A (en)
AR (1) AR012435A1 (en)
AU (1) AU744528B2 (en)
BG (1) BG103861A (en)
BR (1) BR9809088A (en)
CA (1) CA2287465A1 (en)
CO (1) CO4940439A1 (en)
HU (1) HUP0001402A3 (en)
IL (1) IL131892A0 (en)
NO (1) NO995033L (en)
NZ (1) NZ337844A (en)
PL (1) PL336262A1 (en)
SK (1) SK142099A3 (en)
TR (1) TR199902456T2 (en)
TW (1) TW458977B (en)
WO (1) WO1998046603A1 (en)
ZA (1) ZA982912B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
HU229604B1 (en) * 2001-02-12 2014-02-28 Hoffmann La Roche 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
KR20070086076A (en) 2004-11-12 2007-08-27 트러스티즈 오브 터프츠 칼리지 Lipase inhibitors
WO2008121257A1 (en) * 2007-03-28 2008-10-09 Merck & Co., Inc. Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
AU2013326867B2 (en) * 2012-10-05 2018-03-08 Rigel Pharmaceuticals, Inc. GDF-8 inhibitors
US10016432B2 (en) 2016-05-27 2018-07-10 Legacy Emanuel Hospital & Health Center Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
AR012435A1 (en) 2000-10-18
ZA982912B (en) 1998-10-09
EP0979230A1 (en) 2000-02-16
TW458977B (en) 2001-10-11
HUP0001402A2 (en) 2000-10-28
CN1259948A (en) 2000-07-12
BR9809088A (en) 2000-08-01
AU744528B2 (en) 2002-02-28
CA2287465A1 (en) 1998-10-22
NO995033L (en) 1999-12-15
PL336262A1 (en) 2000-06-19
TR199902456T2 (en) 2000-07-21
NZ337844A (en) 2001-11-30
SK142099A3 (en) 2000-05-16
KR20010006453A (en) 2001-01-26
NO995033D0 (en) 1999-10-15
CO4940439A1 (en) 2000-07-24
HUP0001402A3 (en) 2001-01-29
AU7098198A (en) 1998-11-11
IL131892A0 (en) 2001-03-19
JP2001520649A (en) 2001-10-30
WO1998046603A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
UA66825C2 (en) Azapolycyclic compounds condensed with aryl
TR200000837A2 (en) Process and intermediates to prepare anti-cancer compositions.
CA2178974A1 (en) Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor
MY121047A (en) Bicyclo [2.2.1] heptanes and related compounds
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
PL315193A1 (en) Diazabicyclic antagonists of neurokinin
YU11501A (en) 4,4-biarylpiperidine derivatives with opioid receptor activity
CA2401229A1 (en) Aryl fused azapolycyclic compounds
CA2216129A1 (en) Lactam-containing hydroxamic acids
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
KR940014396A (en) Imidazopyridine
IL133891A0 (en) 2-valproenoic acid amide derivatives, their preparation and pharmaceutical compositions containing them
CA2269994A1 (en) 7-hetero-bicyclo¬2.2.1|-heptanes
TW372237B (en) 1-2-4 triazolo[1,5-a]pyrimidines, pharmaceutical compositions containing them for treatment and/or prophylaxis of seizures, neurological disorders and/or conditions in which there is neurological damage, and processes for their preparation
MX9701819A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents.
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
BG103842A (en) 5,7-DIMOSTATED 4-AMINOPYRIDO [2,3-D] PYRIMIDINO-SUBSTITUENTS AND THEIR USE AS ADENOSINE KINASE INHIBITORS
BG104983A (en) Aryl fused azapolycyclic compounds
GR3034354T3 (en) IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
ATE144423T1 (en) THERAPEUTIC BENZAZEPINE COMPOUNDS
BG103853A (en) 5, 6, 7-trisubstituted 4-aminopyridol[2,3-d]pyrimidine compounds
WO2002044191A3 (en) Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
TR199902456T2 (en) 6,7-ikameli-4-aminopyrido$2,3,-D]Pirimidin bile�ikleri.
AU2001276200A1 (en) Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction